February 19, 2003
Best Life International Has Recalled
Ancom Anti-Hypertensive Compound Tablets
The Food and Drug
Administration (FDA) said that Best Life International, Inc. has recalled
all 100 tablet bottles of Ancom Anti-Hypertensive Compound Tablets, an
unapproved new drug labeled to contain several prescription drug
ingredients, including reserpine, diazepam, promethiazine, and
hydrochlorothiazide. The sale of a product with this combination of
ingredients poses possible serious health risks including sedation,
depression, and potentially life-threatening abnormalities of the blood.
This recall includes all lot codes of the product remaining on the market.
Ancom Tablets were sold without prescriptions to consumers through
distributors and retail stores of natural products throughout the Island of
Puerto Rico. The product is labeled for anti-hypertensive use and is
packaged in white plastic bottles of 100 tablets bearing blue and white
lettered labeling. Each bottle is sold in an outer cardboard holding carton.
Both the carton and immediate container label bear the product name as Ancom
tablets, Anti-hypertensive Compound, and display the manufacture?s name as
Shanghai Pharmaceutical Industry Corp., Shanghai, China. The labeling also
bears Chinese markings, which appear to be dual declarations. The holding
carton is white with a pink and blue vertical stripe bearing blue and white
lettering. The product carton also includes a pre-printed insert labeled
with an ingredient statement and directions for use.
Consumers who have used this product and are experiencing any adverse
reactions should seek advice from their physician for appropriate evaluation
and treatment of their hypertension.
Consumers who purchased Ancom Anti-Hypertensive Compound Tablets are urged
to immediately discontinue use of the product and return it to the place of
purchase for a full refund. Consumers with questions may contact the company
This recall is being conducted in cooperation with the U.S. Food and Drug
Any adverse reactions experienced with the use of this product should be
US Food and Drug Administration San Juan District 1-800-FDA-0127.